Further investigations of our study identified that miR-9-3p inhibition led to increase of cell proliferation and decrease of apoptosis in vitro and promotion of tumorigenesis in vivo and reversed the effect of SNHG1 silencing in bladder cancer. The gene discussed is SNHG1; the disease is urinary bladder carcinoma.